Kymanox Exhibits at the 2017 PDA/FDA Joint Regulatory Conference

Kymanox New

For more than 25 years, the U.S. FDA and PDA have collaborated on the PDA/FDA Joint Regulatory conference. Participants have the opportunity to engage directly with FDA representatives and hear updates on current efforts affecting the development of global regulatory strategies. Industry experts present case studies illustrating how they use global strategies to improve the quality of medical products. This year’s theme was “Ensuring Product Quality in an Era of Innovative Therapies.” Kymanox team members attended and exhibited at both days of the conference, and connected with several industry executives.